Concepedia

Baricitinib is Effective in Treating Progressing Vitiligo in vivo and in vitro

Jie Dong, Xuan Huang, Li-Ping Ma, Qi Fei, Si‐Nian Wang, Zi-Qin Zhang, Shi‐Nan Wei, Ling Gao, Fang Liu

Dose-Response · 2022 · 46 citations · 10 references

DOIFull text

Open access

Abstract

Our preliminary study showed that baricitinib was effective and safe in treating progressing vitiligo. Baricitinib could promote tyrosinase activity, melanin content and TYR, TRP1 gene expression of MC-Ds in vitro.

References

10

Baricitinib in Patients with Refractory Rheumatoid Arthritis

Mark C. Genovese, Joel Kremer, Omid Zamani et al. · New England Journal of Medicine · 2016 · 598 citations · Full text

Parametric Modeling of Narrowband UV-B Phototherapy for Vitiligo Using a Novel Quantitative Tool

Iltefat Hamzavi, Hem C. Jain, David I. McLean et al. · Archives of Dermatology · 2004 · 425 citations

A Mouse Model of Vitiligo with Focused Epidermal Depigmentation Requires IFN-γ for Autoreactive CD8+ T-Cell Accumulation in the Skin

John E. Harris, Tajie H. Harris, Wolfgang Weninger et al. · Journal of Investigative Dermatology · 2012 · 364 citations · Full text

Tofacitinib Citrate for the Treatment of Vitiligo

Brittany G. Craiglow, Brett King · JAMA Dermatology · 2015 · 251 citations · Full text

Repigmentation in vitiligo using the Janus kinase inhibitor tofacitinib may require concomitant light exposure

Lucy Liu, James P. Strassner, Maggi Ahmed Refat et al. · Journal of the American Academy of Dermatology · 2017 · 226 citations · Full text

, , +8